---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-107485"
form_type: "8-K"
ticker: "VYNE"
cik: "0001566044"
company_name: "VYNE Therapeutics Inc."
filed_at: "2026-09-14T20:01:20+00:00"
generated_at: "2026-09-14T20:02:08.308802+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Yarrow Bioscience raises ~$161.8M in public offering of common stock

## Summary
- Sold 5,769,231 shares at $26.00/share; underwriters exercised full option for 865,384 additional shares.
- Net proceeds expected ~$161.8M after underwriting discounts and estimated offering expenses.
- Offer led by Jefferies LLC, TD Securities (USA) LLC and Guggenheim Securities; closing expected Sept 14, 2026.
- Directors and executive officers subject to 60-day lock-up; shelf registration S-3 declared effective Aug 19, 2026.

## SEC filing metadata
- accession: 0001104659-26-107485
- form_type: 8-K
- ticker: VYNE
- cik: 0001566044
- company_name: VYNE Therapeutics Inc.
- filed_at: 2026-09-14T20:01:20+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1566044/000110465926107485/0001104659-26-107485-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1566044/000110465926107485/tm2624918d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-107485
- JSON: https://secwatch.observer/filing/0001104659-26-107485.json
- Plain text: https://secwatch.observer/filing/0001104659-26-107485.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.